• A Five Years Budget Impact Analysis of The Introduction of Adalimumab For Crohn’s Disease Patients From The Perspective of The Brazilian Private Health Care System

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Proton Pump Inhibitor Initiation Aimed to Prevent Upper Gastrointestinal Toxicity in Patients Using Low-Dose Acetylsalicylic Acid

    Nov 1, 2015, 00:00

  • Costs of Type 1 Diabetes Mellitus in Pediatric Patients in Spain- Chrystal Observational Study

    Nov 1, 2015, 00:00

  • Prescription Pattern Of Antihypertensive Agents In A Tertiary Care Teaching Hospital In Central Nepal

    Nov 1, 2015, 00:00

  • Development of A Validated Questionnaire Evaluating The Burden of The Haemorrhoidal Disease and Anal Fissure (Hemo-Fiss)

    Nov 1, 2015, 00:00

  • Challenges Along The Road to Universal Health Coverage In Egypt, An Hio Perspective

    Nov 1, 2015, 00:00

  • Access to Innovative Drugs in Patients with Metastatic Lung Cancer in French Public Hospitals (the Territoire Study)

    Nov 1, 2015, 00:00

  • Potential Health And Economic Impact Of Introducing A Dengue Vaccine In Malaysia- Assessment Using Dynamic Transmission Modelling

    Nov 1, 2015, 00:00

  • Can Qva149 Improve Short Term Outcomes In Patients With Copd Without Increasing The Overall Treatment Costs For The Portuguese Nhs? Optimizing Treatment Outcomes With A Responsible Use Of Limited Resources

    Nov 1, 2015, 00:00

  • Pen Devices for Insulin Administration Compared to Needle And Vial- Systematic Review of Literature and Meta-Analysis

    Nov 1, 2015, 00:00

  • Epidemiology of Hepatitis C Patients In Italian Local Health Units (Lhus)

    Nov 1, 2015, 00:00

  • Systematic Review Of Thermal Massage Therapy For The Treatment Of Dry Eye Syndrome

    Nov 1, 2015, 00:00

  • The British Isles Hta League Table 2014

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Everolimus In Liver Transplantation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Canacinumab In The Treatment of Patients Suffering From Systemic Juvenile Idiopathic Arthritis In Russian Federation

    Nov 1, 2015, 00:00

  • The Importance of Inhaler Devices- An Incorrect Inhaler Technique Leads to Suboptimal Medication Compliance In Patients With Copd

    Nov 1, 2015, 00:00

  • Percentage Price Variation Among Antidepressant Drugs in Indian Market- an Economic Perspective

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Transthyretin Familial Amyloid Polyneuropathy

    Nov 1, 2015, 00:00

  • Novel Oral Anticoagulant Use In The Eu5- How Are Payer Policies And Physician Preferences Shaping The Prescribing Landscape?

    Nov 1, 2015, 00:00

  • Off-Patent Drugs Consumption And Expenditures In Italy- 2009-2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

    Nov 1, 2015, 00:00

  • Cost-Utility Of Statin In Secondary Prevention- A Propensity Score Method Of Administrative Database

    Nov 1, 2015, 00:00

  • Patterns of Care with Biological Drugs for Ankylosing Spondylitis- Real-World Data from the Private Healthcare Market in Brazil

    Nov 1, 2015, 00:00

  • Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Quality Of Life In Asthma

    Nov 1, 2015, 00:00

  • Hrqol And Health Utility Impact On Patients With Newly Diagnosed Multiple Myeloma In Us And Europe- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Assessing The Treatment of Peripheral Neuropathic Pain (Pnep) And Postherpetic Neuralgia (Phn) In China Using A Simulation Model

    Nov 1, 2015, 00:00

  • 36 Months Pangaea- A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice

    Nov 1, 2015, 00:00

  • Analisis De Costo Efectividad Del Diagnostico De La Distrofia Muscular De Duchenne O Becker En Colombia

    Nov 1, 2015, 00:00

  • The Effect Of A Telephone Counseling Intervention By Pharmacist On Patients’ Beliefs About Medicines And Blood Pressure Control

    Nov 1, 2015, 00:00

  • Lead Damage in the First-Year Following Cardiac Implantable Electronic Device (Cied) Replacement- Incidence and Costs Based on Device Type

    Nov 1, 2015, 00:00

  • Jósa András Hospital Complex Project - Cost-Benefit Analysis Of The Major Project Investment

    Nov 1, 2015, 00:00

  • Adherence to Initiated Basal Insulin Analog Treatment In Type 1 and 2 Diabetes

    Nov 1, 2015, 00:00

  • Real World Evidence And Costs Of Chronic Heart Failure- Findings From 41,413 Patients Of The Arno Database

    Nov 1, 2015, 00:00

  • Glaucoma- Highlight Molecules Used In Patients From Supplementary Health In Brazil

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dapagliflozin as Add-on to Metformin for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2015, 00:00

  • Impact of A Payment By Results Access Scheme In Italy- Better Value For Money?

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Drug Coated Balloon Versus Percutaneous Transluminal Balloon Angioplasty In The Treatment of Peripheral Arterial Disease In Lower Limbs In Brazil

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Fluticasone Propionate/Formoterol Fumarate (Flutiform®) Vs Fluticasone/Salmeterol And Budesonide/Formoterol In Spain

    Nov 1, 2015, 00:00

  • Terlipressin Versus Noradrenaline In The Treatment Of Hepatorenal Syndrome – Systematic Review With Meta-Analysis And Full Economic Evaluation

    Nov 1, 2015, 00:00

  • Modeling Of Risks And Benefits Of Lung Cancer Screening Strategies Using Low-Dose Helical Ct (Ldct) Technology In Canada

    Nov 1, 2015, 00:00

  • An Overview of Reviews of The Clinical Effectiveness of Generic Chronic Disease Self Management Support Interventions

    Nov 1, 2015, 00:00

  • Assessment Of Major Molecular Response (Mmr) And Complete Cytogenetic Response (Ccyr) As Surrogate Outcomes Of Survival In Chronic Myeloid Leukemia Chronic Phase (Cml-Cp) Patients

    Nov 1, 2015, 00:00

  • What Do we Mean When we Talk About “U.S. Spanish”?

    Nov 1, 2015, 00:00

  • Resource Utilization In Patients With Advanced Melanoma In France

    Nov 1, 2015, 00:00

  • Associations Of Metformin Use With Mortality And Disease Progression After Curative Hepatic Resection In Hepatocellular Carcinoma With Type 2 Diabetes Mellitus- A Nationwide Population-Based Study

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Screening for Colorectal Cancer In Argentina

    Nov 1, 2015, 00:00

  • Measurement of the burden, resources use and health costs associated with herpes zoster and post-herpetic neuralgia in mexico. Master study

    Nov 1, 2015, 00:00

  • Standardization Process Of Raw Datasus And Consumption Analysis Of Oncology Therapies In The Brazil Public Health Care System- A Comparison Between Raw And Standardized Dataset In Colorectal And Lung Cancer

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Idelalisib Plus Rituximab In Chronic Lymphocytic Leukaemia

    Nov 1, 2015, 00:00

  • A Study on Health Care Professional’s Sense of Ethics In Japan

    Nov 1, 2015, 00:00

  • Budget Impact Model (Bim) Of Rivaroxaban In Comparison With Enoxaparin Plus Warfarin In The Treatment Of Venous Thromboembolism (Vte) Under The Perspective Of The Private Health System

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

    Nov 1, 2015, 00:00

  • Lagrange Method for Budget Optimization Analysis in Resource Allocation for Antipsychotic Therapies in Colombia

    Nov 1, 2015, 00:00

  • Health Related Quality of Life In Patients With Diabetic Foot Ulceration – Observational Study In Poland

    Nov 1, 2015, 00:00

  • Medical Devices- Why Do Some Pay More Than Others Do? Analysis Of Price Variation In French Public Hospital In 2013

    Nov 1, 2015, 00:00

  • Analysis Of Eribulin Mesylate Dosing Modifications Impact On Administration Persistence In Patients With Metastatic Breast Cancer (Mbc)

    Nov 1, 2015, 00:00

  • Simulation optimisation of Treatment Sequences for Rheumatoid arthritis

    Nov 1, 2015, 00:00

  • The Prostate Cancer Registry- Analysis of Medical Resource Utilisation (Mru) in An International, Prospective, Observational Study of Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

    Nov 1, 2015, 00:00

  • Body Image and Sexual Problem in Young Breast Cancer Patients in South Indian Population

    Nov 1, 2015, 00:00

  • Health Care Policy and Cost After Earthquake In Nepal

    Nov 1, 2015, 00:00

  • Real-World Identification Of European Patients With Statin-Associated Symptoms- Clinical Practice Compared With Clinical Guidelines

    Nov 1, 2015, 00:00

  • Does Treatment Adherence Correlates With Health-Related Quality of Life- Findings From A Cross Sectional Analysis of Type 2 Diabetes Mellitus Patients In Pakistan

    Nov 1, 2015, 00:00

  • An Assesment Of Enoxaparine Benefit On Healthcare Budget In Spain

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Aripiprazole Once-Monthly Versus Paliperidone Palmitate in the UK- Findings From Qualify

    Nov 1, 2015, 00:00

  • A Review of Cost Effectiveness Studies of Rheumatoid Arthritis (Ra) Interventions In The Uk And Us

    Nov 1, 2015, 00:00

  • Identification Of Subgroups With Low Rates Of Smoking Cessation In Israel

    Nov 1, 2015, 00:00

  • A Multivariate Safety and Efficacy Analysis of Prescribing Information for Next Generation SGLT-2 Inhibitors in Type 2 Diabetes Treatment

    Nov 1, 2015, 00:00

  • Costs to U.S. Health Insurers for Hematopoietic Stem Cell Transplant (Hct) Recipients with Double Stranded Dna (Dsdna) Virus Infections Following Transplant

    Nov 1, 2015, 00:00

  • The Impact Of Self-Monitoring Of Blood Glucose (Smbg) On Prescription Costs In Newly Treated Type 2 Diabetes Melitus (T2dm)- A Retrospective Cohort Analysis

    Nov 1, 2015, 00:00

  • Risk Factors For Dementia Diagnosis In German Primary Care Practices

    Nov 1, 2015, 00:00

  • Factors Influencing Treatment Duration In Metastatic Colorectic Cancer Patients Treated With Ziv-Aflibercept- A Real World View

    Nov 1, 2015, 00:00

  • Use of Economic Evaluations of Health Technologies In Dutch Healthcare Decision-Making- Barriers And Facilitators

    Nov 1, 2015, 00:00

  • Cost-Utility and Budget Impact Analyses Comparing Lurasidone with Aripiprazole in Adults with Schizophrenia in Scotland

    Nov 1, 2015, 00:00

  • Oncology Literature Bank For Cancers And Therapies For Heor- Concept And Utilization Of Oncolitbank

    Nov 1, 2015, 00:00

  • Potential Public Resource Savings In Brazil- The Somatropin Case

    Nov 1, 2015, 00:00

  • Descriptive Evaluation of Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Malignant Neoplasm of Anus

    Nov 1, 2015, 00:00

  • Analysis Of Evidence Data About Adding Succinic Acid To The Various Medicines

    Nov 1, 2015, 00:00

  • Burden of Anemia Among Indian Women- A Systematic Review And Meta-Analysis of Literature

    Nov 1, 2015, 00:00

  • A Participação do Departamento de Ciência e Tecnologia do Ministério da Saúde Na Revisão e Atualização da Rename

    Nov 1, 2015, 00:00

  • Economic Benefits Associated With Nt-Probnp Test In Brazil and Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pneumococcal Vaccination of Elderly In Germany

    Nov 1, 2015, 00:00

  • Elderly Osteoporosis Suspects without Diagnosis – Interim Data from a German Geriatric Practice

    Nov 1, 2015, 00:00

  • Consumer Interest in Adopting an Electronic Health Record (EHR) Mobile Application Based on the Risk that Identifiable Information is Leaked

    Nov 1, 2015, 00:00

  • The Influence of “Has” Haute Autorite De Sante In The Reimbursement Decisions In Francophone Countries- The Case of North Africa Region

    Nov 1, 2015, 00:00

  • How To Conduct Economic Evaluations Of New Treatments For Advanced Cancer When Overall Survival Data Are Not Available? Results From A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Trends In Health Technology Assessment Decisions Across The Globe- A Focus on Hepatitis C

    Nov 1, 2015, 00:00

  • Assessing The Impact of Growth Hormone Deficiency (Ghd) In Children- Concept Elicitation Results Supporting The Development of The Treatment-Related Impact Measure for Childhood Ghd (Trim-Cghd)

    Nov 1, 2015, 00:00

  • Effectiveness of Allopurinol In Achieving And Sustaining Target Serum Urate- An Analysis of A National Integrated U.S. Healthcare System

    Nov 1, 2015, 00:00

  • Verification and Validation of Health Economic Models for Diabetes

    Nov 1, 2015, 00:00

  • Cost of Adverse Drug Events on Health Resources Utilizaton in Older Adult Singaporeans

    Nov 1, 2015, 00:00

  • Examination of the Effect of Clinical Practices among Nursing Students

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Study Of The Use Of Rituximab For Subcutaneous Administration In The Treatment Of Follicular Lymphoma

    Nov 1, 2015, 00:00

  • Costos de Infección Respiratoria Aguda Grave Asociada Al Virus de La Influenza en Colombia

    Nov 1, 2015, 00:00

  • The Issue for Sexuality After Cervix Cancer Treatment Among Woman

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu)

    Nov 1, 2015, 00:00

  • Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)

    Nov 1, 2015, 00:00

  • Discount Distribution Analysis of Original Medicines Which Has No Generics In Turkey

    Nov 1, 2015, 00:00

  • Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy- Observations Based on Real-World Data

    Nov 1, 2015, 00:00

  • Filling the Gap Between Risk/Benefit Assessment for Drugs and Risk Assessment for Consumer Goods

    Nov 1, 2015, 00:00

  • The Acceptance Of Morbidity Endpoints In The Amnog Process In Germany- Are There Greater Hurdles For Substances Within Oncology?

    Nov 1, 2015, 00:00

  • Peculiarity, Environmental and Chronic Diseases- Using Ecological Models as a Framework for Analysising Risk Factors of Chronic Diseases

    Nov 1, 2015, 00:00

  • Burden of Cost in Bronchiolitis Obliterans Syndrome (Bos)- Predictions for the Next Decade

    Nov 1, 2015, 00:00

  • The Use of Interquartile Deviation in Establishing Delphi Panel Consensus- A Prioritization of Intravenous Immunoglobulin Utilization

    Nov 1, 2015, 00:00

  • Real World Data On Colony-Stimulating Factors (Csf) In Oncology- Patterns Of Use In Brazil

    Nov 1, 2015, 00:00

  • Association Between Adherence to Evidence-Based Heart Failure Drug Treatment and One-Year All-Cause Hospitalization and All-Cause Mortality

    Nov 1, 2015, 00:00

  • Decontamination and Infection Control of Nursing Tools and Patient Environment Regarding Nosocomialis Infections

    Nov 1, 2015, 00:00

  • Efficacy Comparison of Anti-Vegf and Laser Photocoagulation in the Treatment of Visual Impairment due to Diabetic Macular Edema- a Systematic Review and Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Impact of The Changes In The Portuguese Pharmacy Remuneration System

    Nov 1, 2015, 00:00

  • Performance Score Extraction from Panel Data for Multi-Criteria Decision Analysis (Mcda) Using a Regression-Based Approach

    Nov 1, 2015, 00:00

  • Impact of A Telephonic Outreach Program on Medication Adherence In Medicare Advantage Prescription Drug (Mapd) Plan Beneficiaries

    Nov 1, 2015, 00:00

  • Systematic Review and Mixed Treatment Comparison of Therapies for Diabetic Macular Edema

    Nov 1, 2015, 00:00

  • Impact Of Heart Failure On Hospital Admissions And Mortality In Spain In The Period 2009-2013

    Nov 1, 2015, 00:00

  • Development, Test-Retest Reliability And Validity of the Pharmacy Value Added Services Questionnaire

    Nov 1, 2015, 00:00

  • Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Comparison Of Treatment Duration Among Targeted Agents In Renal Cell Carcinoma (Rcc)

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us)

    Nov 1, 2015, 00:00

  • Análisis Costo-Utilidad Del Manejo Integral De Las Pacientes Con Carcinoma De Seno Tratadas Con Reconstruccion De Seno Inmediata Vs. Diferida En Colombia

    Nov 1, 2015, 00:00

  • Evaluación Costo-Utilidad De Dos Alternativas De Vacunación Para El Virus Del Papiloma Humano (Vph) En La Prevención Del Cancer Cervical Uterino

    Nov 1, 2015, 00:00

  • Assessment of Compliance and Avoided Costs After Implementation of Equivalent Terapeutic Program for Candida Infection Treatment

    Nov 1, 2015, 00:00

  • Better Reimbursement Decision-Making Based on Expected Cost-Effectiveness- Using Value of Information Decision Analysis to Improve The Design and Efficacy of A Phase Iii Program for Erlotinib

    Nov 1, 2015, 00:00

  • Does The Legal Regulation Of Promoting Pharmaceutical Parallel Imports Helps To Create Savings For The Statutory Health Insurance (Gkv) In Germany?

    Nov 1, 2015, 00:00

  • Join Progress A Efficiency Partnership Program on Knee Joint Replacement

    Nov 1, 2015, 00:00

  • Healthcare Resource Utilization Associated with Varicella in Argentina

    Nov 1, 2015, 00:00

  • Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico- Results from a Large Patient Support Program in Mexico

    Nov 1, 2015, 00:00

  • Análisis De Minimización De Costos Del Uso De Trastuzumab Subcutáneo Frente A Trastuzumab Intravenoso En El Tratamiento De Cáncer De Mama Temprano En Mujeres Con Her2 Positivo Para Venezuela

    Nov 1, 2015, 00:00

  • Costo – Efectividad De Apixaban Con Otros Noacs (Dabigatran Y Rivaroxaban) En El Tratamiento De La Fibrilacion Auricular No Valvular (Fanv) En Pacientes De La Seguridad Social De Perú

    Nov 1, 2015, 00:00

  • Sensitivity Analysis In Discrete Choice Experiments For Rare Diseases – An Analysis Within The Piano-Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Chile

    Nov 1, 2015, 00:00

  • Assessment of Drug Prescribing Among Pregnant Women Attending Antenatal Out Patient Department of A Referral Hospital In Ethiopia

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Study On The Increased Intake Of Potassium And Vitamin B2 Among Adults In China

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18f-Fdg Pet/Ct for Screening Distant Metastasis in Stage Ii/Iii Breast Cancer Patients of the UK, the United States and the Netherlands

    Nov 1, 2015, 00:00

  • Natalizumab Use In Multiple Sclerosis- A Real World Evidence (Rwe) Analysis of Its Impact on Nhs Resources In England

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland

    Nov 1, 2015, 00:00

  • Health And Economic Outcomes Related to Delay Between Medical Indication and Treatment With Ranibizumab In Age-Related Macular Degeneration In Greece

    Nov 1, 2015, 00:00

  • Identifying Current Treatment Practices In Non-Hodgkin’s Lymphoma

    Nov 1, 2015, 00:00

  • Does The Atu Process Have An Impact On Time To Market Launch?

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland- a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone M ...

    Nov 1, 2015, 00:00

  • Incorporation Of Evidence Based Medicine Into The European Observatory On Health Systems And Policies Document Describing The Health Systems Of Countries Not Belonging To The European Union

    Nov 1, 2015, 00:00

  • Loss Of Opportunity Linked With The Suboptimal Coverage Rate Of Hpv Vaccination In France

    Nov 1, 2015, 00:00

  • Economic Considerations In Clinical Guidelines - Are Patient Perspectives Considered?

    Nov 1, 2015, 00:00

  • Structured Review Of Patient Quality Of Life Following Diagnosis With Prostate Cancer

    Nov 1, 2015, 00:00

  • The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey

    Nov 1, 2015, 00:00

  • Direct Medical Costs Associated with Multiple Myeloma in Chinese Patients- Estimations from China Public Health Insurance Claim Data

    Nov 1, 2015, 00:00

  • Economic Burden of Pneumococcal Infections In Children Under Five Years Old

    Nov 1, 2015, 00:00

  • Primary Care Dementia Clinic Reduces Societal Cost of Dementia- A Cost-Utility Analysis

    Nov 1, 2015, 00:00

  • Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

    Nov 1, 2015, 00:00

  • A Pilot Study of Direct Costs for Patients With Rheumatoid Arthritis In Bulgaria

    Nov 1, 2015, 00:00

  • Introducing Orange- An International Price Reference Tool

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Double-Blind Phase Iii Studies of Brivaracetam As Adjunctive Therapy of Partial-Onset Seizures

    Nov 1, 2015, 00:00

  • A Study on Cytogenetic Analyses and Mecp2 Mutation With Dopamine And Serotonin In Rett Syndrome (Rtt)

    Nov 1, 2015, 00:00

  • Clinical, Mediciation and Economical Outcome Research of Advanced Colorectal Cancer Relapse Using Reimbursement and Cancer Registry Databases

    Nov 1, 2015, 00:00

  • Economic Burden in Studies Published in 2014- What Type of Mental Health Disorders and Outcomes Have Been Most Commonly Assessed?

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis of Different Oral Antiviral Medications In Patients With Chronic Hepatitis B In Iran- An Economic Micro-Simulation Decision Model

    Nov 1, 2015, 00:00

  • Analysis Of Primary And Secondary Apr-Drg Codes Of An Ischemic Stroke Admission

    Nov 1, 2015, 00:00

  • Treatment Strategies, Health Care Resource use and Costs of Aggressive Histological types of non-Hodgkin Lymphomas in the Slovak Republic. Results from the Cross-Sectional Survey in the Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Translatability Assessment and Linguistic Validation of The Patient-Reported Outcome Instrument for Irritable Bowel Syndrome With Diarrhea (Ibs-D Pro)

    Nov 1, 2015, 00:00

  • Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints

    Nov 1, 2015, 00:00

  • G-Ba Does not Adjust Evidence Requirements in Early Benefit Assessment in Cases of Pre-Defined, Efficacy-Based Cross-Over Decisions in Oncology Trials

    Nov 1, 2015, 00:00

  • Therapeutic Reference Pricing System In Slovenia From The Patients’ Perspective

    Nov 1, 2015, 00:00

  • Ten Years of The International Pompe Survey- Patient Reported Outcomes As A Reliable Tool for Studying Treated and Untreated Children and Adults With Non-Classic Pompe Disease

    Nov 1, 2015, 00:00

  • Clinical Multi-Criteria Decision Assessment (Cmda)- A Proposal for Applying Mcda to Compare Treatments in a Simultaneous, Transparent and Overall Way

    Nov 1, 2015, 00:00

  • Eroltinib Plus Gemcitabine Compared With Gemcitabine Monotherapy In Patients With Pancreatic Cancer- A Real-World Analysis Of Korean Nationa-Wide Database

    Nov 1, 2015, 00:00

  • Full Economic Assessment of Rotavirus Vaccination Using the Health Economic Cauliflower Toolbox

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis To Assess Relative Efficacy Of Ibrutinib Versus Idelalisib+Ofatumumab And Physician’s Choice In Relapsed/Refractory Cll Patients

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Tiotropium In The Treatment Of Patients With Asthma

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utilities for Adults With Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Regional Versus Centralized Hta- Implications for the Assessment of Cancer Drugs

    Nov 1, 2015, 00:00

  • Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods- a Case Study in Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Vivascope© For Diagnosing Melanoma- A Systematic Review

    Nov 1, 2015, 00:00

  • “First And Foremost Battle The Virus” - Patient Preferences In Antiviral Therapy For Hepatitis C

    Nov 1, 2015, 00:00

  • The Effect of Stress and Coping Resources on Predicting Quality of Life of Graduate Students

    Nov 1, 2015, 00:00

  • Trastuzumab Emtansine for Her2 Positive Breast Cancer Patients- an Updated Systematic Review

    Nov 1, 2015, 00:00

  • Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis

    Nov 1, 2015, 00:00

  • Patient Versus General Population Health State Valuations- A Case Study Of Low Back Pain

    Nov 1, 2015, 00:00

  • ESTIMATION OF THE TRESHOLD PRICE OF REGORAFENIB IN THE TREATMENT OF UNRESECTABLE AND/OR METASTATIC GASTROINTESTINAL STROMAL TUMORS AFTER FAILURE ON IMATINIB AND SUNITINIB IN SPAIN- COST-UTILITY ANALYSIS

    Nov 1, 2015, 00:00

  • Quantitative Assessment of Therapeutic Value of Innovative Medical Technologies- Methodology and Preliminary Results

    Nov 1, 2015, 00:00

  • Can Actigraphy Outcome Measures From Existing Clinical Trials Provide A Framework for Sleep and Activity Endpoint Standards in the Clinical Trial of the Future?

    Nov 1, 2015, 00:00

  • Assessing the Cost-Effectiveness of Therapies in the Third Quadrant on the Cost-Effectiveness Plane

    Nov 1, 2015, 00:00

  • Modelling to Determine the Price and Identify Critical Data Gaps During Vaccine Development

    Nov 1, 2015, 00:00

  • Trends Of Sick-Pay Benefits In Hungary Between 2005-2013

    Nov 1, 2015, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Saudi Arabia

    Nov 1, 2015, 00:00

  • Multiple Use Of Antibiotic In Post Operative Patients In Tertiary Care Hospital Of Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Satisfaction with life of general population of pakistan. A nation wide survey

    Nov 1, 2015, 00:00

  • Access Inequalities between Private and Public Insurance Among Cancer Patients- Results of a National Survey in Brazil

    Nov 1, 2015, 00:00

  • Identifying Opportunities For Value-Based Contracting For Molecular Diagnostics As A Means To Improve Outcomes Of Hospital Acquired Infections

    Nov 1, 2015, 00:00

  • The Eu Patient Registry Landscape- Survey of Registry Profiles Through Parent Ja Research And Framework

    Nov 1, 2015, 00:00

  • Prevalence, Comorbidities and Burden of Severe Spondyloarthritis In Fran Analysis of A National Public Health Insurance Database In 2012 In France

    Nov 1, 2015, 00:00

  • The Futility of Cost-Efficacy Analysis

    Nov 1, 2015, 00:00

  • Análisis de costo-efectividad de la warfarina vs. Dabigatrán etexilato en fibrilación auricular en ecuador

    Nov 1, 2015, 00:00

  • Success Rate of Including Medicines to The Reimbursement System In Slovakia

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Enzalutamide For Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc) After Failure Of Androgen Deprivation Therapy (Adt)

    Nov 1, 2015, 00:00

  • Stapled Haemorrhoidopexy To Treat Hemorrhoids Grade Iii And Iv- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Alternative Regression Methods For Mapping Utilities In Oncology

    Nov 1, 2015, 00:00

  • Trends of Research Related Brazil Published in Ispor Meetings- A Bibliometric Analysis from 1998 to 2014

    Nov 1, 2015, 00:00

  • Análisis de Visiones y Percepciones de Potenciales Beneficiarios de la Institucionalización de un Proceso de Evaluación de Tecnologías Sanitarias En Chile- un Estudio Cualitativo

    Nov 1, 2015, 00:00

  • An Eq-5d-5l Value Set Based On Uruguayan Population Preferences- Report Of The First Experience In Latin America

    Nov 1, 2015, 00:00

  • Unique Device Identifier System- The Impact Of The Portuguese Experience

    Nov 1, 2015, 00:00

  • The Impact of Robotic Technology on Neuro-Rehabilitation- Preliminary Results on Acceptability And Effectiveness

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of First-Line Tyrosine Kinase Inhibitors (Tkis) In Newly Diagnosed Chronic Myeloid Leukemia (Cml) Patients In Korea- Comparison Of Dasatinib (100mg), Nilotinib (600mg) And Imatinib (400mg)

    Nov 1, 2015, 00:00

  • Development Of Prescription E-Protocols For Medicines And Integration On The Greek National E-Prescription System

    Nov 1, 2015, 00:00

  • Health-Economic Analysis of The Use of Sensor-Augmented Pump (Sap) Therapy In The Netherlands Compared to Insulin Pump Therapy Alone (Csii), In Type 1 Diabetic Patients

    Nov 1, 2015, 00:00

  • Biosimilar Substitution Policies- An Overview

    Nov 1, 2015, 00:00

  • Methodological Considerations for the Implementation of A European Mandated Retrospective Drug Utilisation Study (Dus) to Investigate the Use of Dexmedetomidine (Dexdor®) in Clinical Practice

    Nov 1, 2015, 00:00

  • Mixed Treatment Comparison to Rank Antiresorptive Agents In Preventing New Non Vertebral Fractures In Postmenopausal Osteoporosis

    Nov 1, 2015, 00:00

  • A Trial-Based Economic Evaluation of Resource use and Costs in the Emilia Clinical Study

    Nov 1, 2015, 00:00

  • The Relation Between Real Costs Of Drugs Temporarily Reimbursed In Mode Of Coverage With Evidence Development And Budget Impact Analysis Submitted As A Mandatory Requirement Of The Application

    Nov 1, 2015, 00:00

  • What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review

    Sep 1, 2015, 00:00

  • Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome- Doubled Costs Compared with Patients with Asthma Alone

    Sep 1, 2015, 00:00

  • Convergence yet Continued Complexity- A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom

    Sep 1, 2015, 00:00

  • Unifying Research and Reimbursement Decisions- Case Studies Demonstrating the Sequence of Assessment and Judgments Required

    Sep 1, 2015, 00:00

  • Copyright/Subscription

    Sep 1, 2015, 00:00

  • Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States

    Sep 1, 2015, 00:00

  • Rare Disease Terminology and Definitions—A Systematic Global Review- Report of the ISPOR Rare Disease Special Interest Group

    Sep 1, 2015, 00:00

  • Erratum

    Sep 1, 2015, 00:00

  • Instructions for Authors

    Sep 1, 2015, 00:00

  • Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder

    Sep 1, 2015, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

    Sep 1, 2015, 00:00

  • Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease- A Population-Based Cohort Study in Finland

    Sep 1, 2015, 00:00

  • Clinical Outcome Assessments- Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

    Sep 1, 2015, 00:00

  • Calculating Preference Weights for the Labor and Delivery Index- A Discrete Choice Experiment on Women’s Birth Experiences

    Sep 1, 2015, 00:00

  • Comparison Costs of ERCP and MRCP in Patients with Suspected Biliary Obstruction Based on a Randomized Trial

    Sep 1, 2015, 00:00

  • Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

    Sep 1, 2015, 00:00

  • Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort

    Sep 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Minimally Invasive versus Open Surgery Techniques for Lumbar Spinal Fusion in Italy and the United Kingdom

    Sep 1, 2015, 00:00

  • Development and Validation of a Score for Adjusting Health Care Costs in General Practice

    Sep 1, 2015, 00:00

  • Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data

    Sep 1, 2015, 00:00

  • Monetary Valuation of Informal Care Based on Carers’ and Noncarers’ Preferences

    Sep 1, 2015, 00:00

  • Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF

    Sep 1, 2015, 00:00

  • Economic Evaluation of the effect of Quitting Smoking on Weight Gains- Evidence from the United Kingdom

    Sep 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

    Sep 1, 2015, 00:00

  • ISPOR Task Force For Clinical Outcomes Assessment- Clinical Outcome Assessments- Conceptual Foundation—Report of The ISPOR Clinical Outcomes Assessment – Emerging Good Practices For Outcomes Research Task Force

    Sep 1, 2015, 00:00

  • Table of Contents

    Sep 1, 2015, 00:00

  • The iMTA Productivity Cost Questionnaire

    Sep 1, 2015, 00:00

  • Economic Evaluations in the Diagnosis and Management of Traumatic Brain Injury- A Systematic Review and Analysis of Quality

    Jul 1, 2015, 00:00

  • When Does FDAMA Section 114 Apply? Ten Case Studies

    Jul 1, 2015, 00:00

  • Cost-Effectiveness of a Nonpharmacological Intervention in Pediatric Burn Care

    Jul 1, 2015, 00:00

  • Table of Contents

    Jul 1, 2015, 00:00

  • Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments

    Jul 1, 2015, 00:00

  • Investigating the Generalizability of Economic Evaluations Conducted in Italy- A Critical Review

    Jul 1, 2015, 00:00

  • Measuring Preferences for a Diabetes Pay-for-Performance for Patient (P4P4P) Program using a Discrete Choice Experiment

    Jul 1, 2015, 00:00

  • Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease- Determinants and Level of Changes Observed

    Jul 1, 2015, 00:00

  • The Social Distribution of Health- Estimating Quality-Adjusted Life Expectancy in England

    Jul 1, 2015, 00:00

  • Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research- An ISPOR Medication Adherence and Persistence Special Interest Group Report

    Jul 1, 2015, 00:00

  • Why Did the Randomized Clinical Trial Become the Primary Focus of My Career?

    Jul 1, 2015, 00:00

  • Goal-Directed Fluid Therapy Guided by Cardiac Monitoring During High-Risk Abdominal Surgery in Adult Patients- Cost-Effectiveness Analysis of Esophageal Doppler and Arterial Pulse Pressure Waveform Analysis

    Jul 1, 2015, 00:00

  • An Analysis of the Public Financial Support Eligibility Rule for French Dependent Elders with Alzheimer’s Disease

    Jul 1, 2015, 00:00

  • The Cost-Effectiveness of Different Hearing Screening Strategies for 50- to 70-Year-Old Adults- A Markov Model

    Jul 1, 2015, 00:00

  • Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression

    Jul 1, 2015, 00:00

  • Extending Treatment Networks in Health Technology Assessment- How Far Should We Go?

    Jul 1, 2015, 00:00

  • An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality

    Jul 1, 2015, 00:00

  • David Sackett 1934–2015

    Jul 1, 2015, 00:00

  • The Cost-Effectiveness of Cognitive-Behavioral Group Training for Patients with Unexplained Physical Symptoms

    Jul 1, 2015, 00:00

  • Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly

    Jul 1, 2015, 00:00

  • A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young Adults

    Jul 1, 2015, 00:00

  • Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia- A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial

    Jul 1, 2015, 00:00

  • Instructions for Authors

    Jul 1, 2015, 00:00

  • HIV Rapid Testing in a VA Emergency Department Setting- Cost Analysis at 5 Years

    Jul 1, 2015, 00:00

  • Copyright/Subscription

    Jul 1, 2015, 00:00

  • Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign

    Jul 1, 2015, 00:00

  • Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time- Results from the Swedish Heart Failure Registry

    Jun 1, 2015, 00:00

  • Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance

    Jun 1, 2015, 00:00

  • Copyright/Subscription

    Jun 1, 2015, 00:00

  • The Continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction

    Jun 1, 2015, 00:00

  • Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes- Systematic Review and Meta-Analysis

    Jun 1, 2015, 00:00

  • Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases- Results from a Health Technology Assessment in Italy

    Jun 1, 2015, 00:00

  • Analysis of Medicine Prices in New Zealand and 16 European Countries

    Jun 1, 2015, 00:00

  • Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy- A Delphi Survey in Belgian Stakeholders

    Jun 1, 2015, 00:00

  • Bringing Patient-Centered Outcomes Research to Life

    Jun 1, 2015, 00:00

  • Instructions for Authors

    Jun 1, 2015, 00:00

  • A Systematic Review of Research Guidelines in Decision-Analytic Modeling

    Jun 1, 2015, 00:00

  • The Lifetime Economic Burden of Inaccurate HER2 Testing- Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

    Jun 1, 2015, 00:00

  • Economics of the Iceberg- Informal Care Provided to French Elderly with Dementia

    Jun 1, 2015, 00:00

  • Assessing the Health-Related Quality of Life of Australian Adolescents- An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments

    Jun 1, 2015, 00:00

  • Assessment of the Quality of the Clinical Evidence in Submissions to the Australian Pharmaceutical Benefits Advisory Committee- Fit for Purpose?

    Jun 1, 2015, 00:00

  • Evaluation of Neuropsychiatric Function in Phenylketonuria- Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria

    Jun 1, 2015, 00:00

  • Decision-Oriented Health Technology Assessment- One Step Forward in Supporting the Decision-Making Process in Hospitals

    Jun 1, 2015, 00:00

  • The Value Adults Place on Child Health and Functional Status

    Jun 1, 2015, 00:00

  • Modeling Health State Utility Values in Ankylosing Spondylitis- Comparisons of Direct and Indirect Methods

    Jun 1, 2015, 00:00

  • Erratum

    Jun 1, 2015, 00:00

  • Table of Contents

    Jun 1, 2015, 00:00

  • Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States- A Disease Transmission Dynamic Modeling Approach

    Jun 1, 2015, 00:00

  • Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs)

    Jun 1, 2015, 00:00

  • Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer

    Jun 1, 2015, 00:00

  • Do Probability and Certainty Equivalent Techniques Lead to Inconsistent Results? Evidence from Gambles Involving Life-Years and Quality of Life

    Jun 1, 2015, 00:00

  • Explaining The Excess Home Health Care Use And Expenditures Among Elderly Medicare Beneficiaries With Parkinson’s Disease

    May 1, 2015, 00:00

  • THE ASSOCIATION BETWEEN ADHERENCE TO CARDIOVASCULAR MEDICATIONS AND HEALTH CARE UTILIZATION

    May 1, 2015, 00:00

  • An Evaluation Of The Use Of Antibiotics In A Teaching Hospital In Bahawalpur

    May 1, 2015, 00:00

  • Cost-Minimization Analysis of Tinzaparin Sodium Compared to Other Low-Molecular-Weight Heparins for Patients With Deep Venous Thrombosis

    May 1, 2015, 00:00

  • Results Of An Intervention In Prescription Of Conventional Release Verapamil In Patients With Hypertension In Colombia

    May 1, 2015, 00:00

  • Assessment of a french Endocrinologist electronic medical Record database for use In observational Studies

    May 1, 2015, 00:00

  • Risk of Cardiotoxicity And All-Cause Mortality In Breast Cancer Patients After Adjuvant Chemotherapy or Hormonal Therapy

    May 1, 2015, 00:00

  • Outcomes, Health Costs And Use Of Statins In 6,226 Patients Admitted In 2011 For An Acute Coronary Syndrome (Acs) Occurring In A Large Community Setting Of 2,989,512 Subjects

    May 1, 2015, 00:00

  • Patterns of treatment modifications in newly treated hypertensive patients- does choice of modification strategy affect likelihood of treatment discontinuation?

    May 1, 2015, 00:00

  • Treatment Satisfaction Among Patients treated with Monotherapy And Adjunctive Antiepileptic Drug Therapies

    May 1, 2015, 00:00

  • Physician care-providing Behavior in treating Attention-Deficit Hyperactive Children and Adolescents

    May 1, 2015, 00:00

  • Medical resource Utilization of acute Myocardial infarction patients with readmission- a retrospective analysis of Hospitalization data from Beijing Medical Insurance database

    May 1, 2015, 00:00

  • Prevalence, Awareness and burden of Major depressive Disorder in Urban China

    May 1, 2015, 00:00

  • Use of Hydrocodone/Acetaminophen- prevalence and estimating Emergency Department visits

    May 1, 2015, 00:00

  • Safety pen needle (SPN) devices in the actue care setting- an analysis of health resource utilization (HRU) in the United States

    May 1, 2015, 00:00

  • Psychometric validation of the Dysphagia Symptom questionnaire in Eosinophilic Esophagitis patients treated with Oral Budesonide Suspension

    May 1, 2015, 00:00

  • Role of indirect comparisons in the amnog Evaluation Procedure

    May 1, 2015, 00:00

  • Antidepressant use in patients with age-related Macular degeneration and depressive symptoms- baseline results from the low vision depression prevention trial

    May 1, 2015, 00:00

  • Pattern of Adjunctive Drug Utilization in oncology Department

    May 1, 2015, 00:00

  • An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom

    May 1, 2015, 00:00

  • The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada

    May 1, 2015, 00:00

  • Mortality and rehospitalization rates among hospitalized pneumonia patients in the u.s. Medicare population

    May 1, 2015, 00:00

  • Evidence Requirements For Future Antiarrhythmic Treatments For Atrial Fibrillation (Af)

    May 1, 2015, 00:00

  • Time Until Insulin Initiation for Canagliflozin (Cana) versus Dapagliflozin (Dapa) In dual and triple Therapy for type 2 diabetes mellitus (T2dm) In Ireland

    May 1, 2015, 00:00

  • Cost/Utility analysis of Pneumococcal Vaccinees Pcv13 Versus Ppsv23 In Adults over 18 Years old in chile

    May 1, 2015, 00:00

  • Systematic review of qualitative studies to identify Health related quality of life constructs reported by patients with Hepatitis C

    May 1, 2015, 00:00

  • Factors and Reasons Associated With Switching In Rheumatoid Arthritis Patients Newly Initiated On Biologic Dmards And Impact on Health Care Resource Utilization In a Managed Care organization

    May 1, 2015, 00:00

  • “Cost Of Illness” Analysis Of Chronic Kidney Disease In The Entire Population Of The Russian Federation

    May 1, 2015, 00:00

  • Functional Status Among Patients With Rheumatic Diseases In The Slovak Republic

    May 1, 2015, 00:00

  • TREATMENT PATTERNS OF MONOTHERAPY VERSUS COMBINATION ANTIEPILEPTIC DRUG THERAPY IN PATIENTS WITH EPILEPSY

    May 1, 2015, 00:00

  • One-Year Cost Outcomes of Early Physical Therapy (PT) Compared With A Usual Care Approach For Patients With Acute Low Back Pain (LBP) Consulting Primary Care

    May 1, 2015, 00:00

  • A Vision ‘Bolt-On’ item increased the sensitivity of EQ-5D in a cross-sectional Health Survey

    May 1, 2015, 00:00

  • Ribavirin does not impact health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in Treatment-NaÏve adults with Genotype 1A (GT1A) Chronic Hepatitis C

    May 1, 2015, 00:00

  • Comparing Healthcare resource Utilization and costs among Schizophrenic patients who initiated typical vs. atypical long-acting injectables in the U.S. veteran Population

    May 1, 2015, 00:00

  • Patient Preferences For Palliative Treatment of Locally Advanced or Metastatic Gastric Cancer and Adenocarcinoma of the Gastrooesophageal Junction- a Choice-Based Conjoint Analysis Study From Germany

    May 1, 2015, 00:00

  • The Amelioration of doxorubicin-induced oxidative Liver Injury by Ursodeoxycholic Acid

    May 1, 2015, 00:00

  • Association Between Osteoarthritis and Workplace Absenteeism

    May 1, 2015, 00:00

  • Classification of non-hiv lipodystrophy in the us using electronic Medical Record (EMR) Data And Physician Notes

    May 1, 2015, 00:00

  • Comparative Effectiveness Research (CER) and its effect on the Health Care decision-making Environment

    May 1, 2015, 00:00

  • Caregivers’ preferences for treatment options in Attention Deficit Hyperactivity Disorder (ADHD)- a latent class analysis

    May 1, 2015, 00:00

  • Health-related quality of life in patients treated with continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis in Singapore

    May 1, 2015, 00:00

  • Evaluation of a pre Hospital Care program for Patients with Triage III-IV

    May 1, 2015, 00:00

  • Antipsychotic use and Foster Care placement stability among youth with Attention-Deficit Hyperactivity/Disruptive Behavior Disorders

    May 1, 2015, 00:00

  • Immune checkpoint inhibitors as adjuvants- future challenges for pricing and reimbursement

    May 1, 2015, 00:00

  • Content Validity Evaluation of A New Diary Developed to Evaluate Symptoms Important to Patients With Moderate to Severe Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Copyright/Subscription

    May 1, 2015, 00:00

  • A Review And Update To The Guidance Document For The Costing Process In The Canadian Health Care Setting

    May 1, 2015, 00:00

  • Hyperkalemia Is Highly Prevalent In Patients With Cardiorenal Comorbidities Compared To Patients Without These Comorbidities

    May 1, 2015, 00:00

  • Universal Versus Targeted Screening of colon Cancers for Lynch Syndrome- Cost and Diagnostic Effectiveness Analyses Based on Clinical Experience

    May 1, 2015, 00:00

  • Safety Profile of Fluoroquinolones- analysis of Adverse Drug Reactions in Relation to Consumption data Using Pharmacovigilance Database in Hebei, China

    May 1, 2015, 00:00

  • Effect of Daily or weekly Glp-1 receptor Agonists on glycemic Control In Insulin-NaÏVe patients With Poorly Controlled type 2 Diabetes- a real-world study

    May 1, 2015, 00:00

  • Overall survival in post-menopausal women with hr+/her2- metastatic breast cancer treated with 1st-line endocrine therapy vs. Chemotherapy

    May 1, 2015, 00:00

  • A Comparison of Healthcare Resource utilization and associated costs in adults with generalized convulsive seizures (GCS)

    May 1, 2015, 00:00

  • Recent Cost Trends Among Patients Using Biologic Agents For The Treatment of Psoriatic Arthritis

    May 1, 2015, 00:00

  • Exploring Medication Use Behaviours- Findings From A Pilot Qualitative Study Conducted Among Community Leaders In The States Of Perak And Kelantan In Malaysia

    May 1, 2015, 00:00

  • Cost Effectiveness of Early Treatment of Parkinson’s Disease in Mexico

    May 1, 2015, 00:00

  • Economic Effectiveness of Ceftaroline fosamil for The Treatment of Hospitalised Patients With Pneumococcal Community-Acquired Pneumonia from a Societal Perspective

    May 1, 2015, 00:00

  • Longitudinal And Cross Sectional Assessments Of Health Utility In Adults With Hiv/Aids- A Systematic Review And Meta-Analysis

    May 1, 2015, 00:00

  • Trends In Patient Centered Research In The Published Literature

    May 1, 2015, 00:00

  • The Association Between Choice Of Balanced Intravenous Crystalloid And Subsequent Major In-Hospital Outcomes Among Adult Patients Undergoing Cardiac Surgery

    May 1, 2015, 00:00

  • Diabetes Education- Patterns and Impact on Medication Adherence

    May 1, 2015, 00:00

  • 14 Day-sequential, concomitant, and Hybrid Therapies for first-line Helicobacter Pylori (H. PYLORI) eradication- a Network meta-analysis

    May 1, 2015, 00:00

  • A Pragmatic Literature Review Of Network Meta-Analyses Of Disease-Modifying Drugs In The Treatment Of Multiple Sclerosis

    May 1, 2015, 00:00

  • Projecting benefits from Weight Loss in Obese Populations- a Microsimulation approach

    May 1, 2015, 00:00

  • Published costs of Medication errors leading to preventable adverse Drug events in US Hospitals

    May 1, 2015, 00:00

  • Multiple Chronic Conditions And Bmi- Population Estimates For Health Decision Making In Puerto Rico

    May 1, 2015, 00:00

  • Preference Values for Hepatitis C-Related Health States from Members of the General Public In Australia, Brazil, France, Italy, and Spain

    May 1, 2015, 00:00

  • Ehealth In The Management Of Chronic Diseases- A Review Of Program Efficacy

    May 1, 2015, 00:00

  • Cost-effectiveness of Rituximab versus Calcineurin inhibitors for refractory Myasthenia Gravis

    May 1, 2015, 00:00

  • Replication Of A Published Markov Chronic Migraine Cost-Effectiveness Analysis Model For Purposes Of Early Phase Adaptation And Expansion

    May 1, 2015, 00:00

  • Disease Burden of Psoriatic Arthritis In Taiwan- A Population-Based Analysis

    May 1, 2015, 00:00

  • Breakthrough Therapy status – expedited FDA regulatory approval but what about the payers?

    May 1, 2015, 00:00

  • The role of cost-effectiveness studies in Drug pricing decisions- a case review from Jordan

    May 1, 2015, 00:00

  • Social And Health Vulnerability Of International Immigrants In Chile- Preliminary Findings From A Spatial Analysis Using 2002-2012 Census Data

    May 1, 2015, 00:00

  • Direct Medical Costs and Associated factors in Patients with Chronic Hepatitis B In Gugngzhou, china- a five-year retrospective Cohort study

    May 1, 2015, 00:00

  • A Cost Analysis Of Kidney Therapy Options

    May 1, 2015, 00:00

  • Pre-Existing Type 2 Diabetes Mellitus and 5-Year Mortality Among Elderly Medicare Beneficiaries With Colorectal Cancer

    May 1, 2015, 00:00

  • Impact of Community Based Therapy on Children with mental health disorders- a health technology assessment

    May 1, 2015, 00:00

  • Attitudes towards Collaboration among Nurses and Physicians practicing in Newly Established Medical homes

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Simvastatin Atorvastatin And Atorvastatin-Ezetimibe Combination Among Patients With Diabetes Mellitus Or Cardiovascular Disease In General Practice

    May 1, 2015, 00:00

  • Cost-effectiveness analysis of Ex-Vivo expanded Autologous Corneal Epithelial Cells containing Stem Cells to repair the damaged ocular surface in Patients with moderate to severe Limbal Stem Cell deficiency due to Ocular Burns in the UK

    May 1, 2015, 00:00

  • Minimally Important Differences for Patient-Reported Outcomes Measurement Information System (Promis) Fatigue and Pain Interference Scores

    May 1, 2015, 00:00

  • An assessment of the Therapeutic Biologic products licensed by the FDA and the EMA

    May 1, 2015, 00:00

  • Persistence And Compliance With Lipid- Lowering Drugs In Patients With Chronic Kidney Disease

    May 1, 2015, 00:00

  • Meta-analysis of Ultrasonic scalpel versus Electrocautery in Laparoscopic Cholecystectomy in China

    May 1, 2015, 00:00

  • Economic Burden and poor quality of life Associated With Acromegaly in the United States

    May 1, 2015, 00:00

  • Importance Of The Conceptual Definition Of Pro Measures- A Case Study With The Linguistic Validation Of The Irritable Bowel Syndrome Quality Of Life (Ibs-Qol) Instrument In 17 Asiatic Languages

    May 1, 2015, 00:00

  • Medical cost-offset of once-monthly Paliperidone palmitate Monotherapy and adjunctive Therapy in 15-month trial

    May 1, 2015, 00:00

  • Barbec(EU)d Oncology market access – how BBQ pulled pork is similar to European PR Negotiations

    May 1, 2015, 00:00

  • Frequency of Increased Maintenance Doses of Adalimumab, Etanercept, And Ustekinumab

    May 1, 2015, 00:00

  • The economic burden of Spinal Muscular Atrophy

    May 1, 2015, 00:00

  • Drug related problems, prescribing pattern and Polypharmacy- evidence from Community Pharmacies in Pakistan

    May 1, 2015, 00:00

  • Cost-Effectiveness of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Canada, Sweden And The Uk

    May 1, 2015, 00:00

  • Treatment for Chemotherapy-Related Cognitive Dysfunction- Review of The Literature

    May 1, 2015, 00:00

  • Calibrating An Integrated Pharmacoeconomic-Pharmacometric Model Of Copd Treatment- What A Difference The Variance Makes

    May 1, 2015, 00:00

  • Assessing Outcomes With Ceftaroline Treatment Compared with Standard of Care among Hospitalized Patients With Complicated Skin And Skin-Structure Infections (Csssi)

    May 1, 2015, 00:00

  • Do different modeling techniques change rankings of hospital performance? - multilevel modeling vs. Standard logistic regression

    May 1, 2015, 00:00

  • Adjusting overall Survival Estimates for Treatment Switching- a Case Study in Metastatic Castration-Resistant Prostate Cancer

    May 1, 2015, 00:00

  • Cost-effectiveness of Breast Cancer screening in the National Breast and Cervical Cancer early detection program in the United States

    May 1, 2015, 00:00

  • Efficacy of Secukinumab in patients with Plaque Psoriasis- area under the curve of treatment response rates

    May 1, 2015, 00:00

  • The Incremental Burden of Obesity and sleep Disorders among Individuals with Type 2 diabetes mellitus

    May 1, 2015, 00:00

  • Reducing maternal and Child Mortality in Ghana- is National Health Insurance scheme’s free maternal care programme helping?

    May 1, 2015, 00:00

  • Diagnostic delay in Patients Diagnosed with Cutaneous Malignant Melanoma

    May 1, 2015, 00:00

  • How influential are Patient and professional group submissions on reimbursement decisions for European Medicines Agency Orphan Drugs?

    May 1, 2015, 00:00

  • Comorbidity And Postoperative Outcomes Among Lung Cancer Patients in the United States

    May 1, 2015, 00:00

  • Sleep Medication Users and their Characteristics

    May 1, 2015, 00:00

  • An analysis of warning letters issued to Pharmaceutical companies regarding misleading Health outcomes claims 2009-2013

    May 1, 2015, 00:00

  • Cost Effectiveness analysis of Most Commonly Prescribed Drugs in Migraine

    May 1, 2015, 00:00

  • Costs And Outcomes Of Patients Admitted For A Cardiovascular Ischemic Disease In A Large Community Setting Of 2,989,512 Subjects Of The Italian National Health Service (Nhs)

    May 1, 2015, 00:00

  • Racial/Ethnic differences in the use of Complementary and Alternative Medicine in Adults with moderate Mental Distress- results from 2012 National Health Interview Survey

    May 1, 2015, 00:00

  • Evaluating the Cost of Bringing People with type 2 Diabetes mellitus to multiple targets of Treatment In Canada

    May 1, 2015, 00:00

  • Impact of 2014 essential Health benefit benchmark plans on us managed care

    May 1, 2015, 00:00

  • Patient-Reported Outcomes (Pros) In Ovarian Cancer Clinical Trials

    May 1, 2015, 00:00

  • Does the generic cancer outcome measure eortc qlq-c30 work in myelofibrosis?

    May 1, 2015, 00:00
  • «
  • 91
  • 92 (current)
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »